I. Meeting Information
The first holders' meeting for the 2026 Employee Stock Ownership Plan of Guangdong Taiankang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") was held on February 25, 2026, via a communication meeting. The meeting notice was delivered to all holders on February 22, 2026, through electronic communication and direct delivery. A total of 166 holders were expected to attend, and all 166 holders participated, representing 33,608,048 shares of the 2026 Employee Stock Ownership Plan, accounting for 100% of the total shares of the plan. The meeting was convened and presided over by Mr. Li Ting, the Secretary of the Board of Directors, and complied with relevant laws, regulations, and the provisions of the 2026 Employee Stock Ownership Plan.